About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

6

Sep

2016

CVS Caremark: Update - New Implementation - Passport Health Plan

See updated COB section below on page 2 of attached PDF

Effective September 1, 2016, CVS Caremark® began to administer the prescription benefits for Passport Health Plan. Please update or create plan member profiles to reflect the following changes regarding the new plan adjudicating through CVS Caremark.
Read More...

6

Sep

2016

OptumRx: UHC Community Plan in Mississippi - New Claims Resolution Process for Therapeutic Dose Limit for Acetaminophen Products

Effective: 10/1/2016

Effective 10/01/2016, new claims processing functionality will make it quicker and easier for you to resolve
Therapeutic Dose Limit (THERDOSE) soft reject edits when dispensing medication for UnitedHealthcare
Community Plan in Louisiana members.

THERDOSE screening monitors single ingredient and combination acetaminophen products across multiple claims to determine cumulative daily use. If claims indicate that acetaminophen usage exceedsthe U.S.  Food and Drug Administration (FDA)-approved maximum daily dose of 4 gm/day, the THERDOSE edit produces a soft reject: Drug Utilization Review (DUR) Reject 88.


Read More...

6

Sep

2016

OptumRx: UHC Community Plan in Louisiana - New Claims Resolution Process for Therapeutic Dose Limit for Acetaminophen Products

Effective: 10/1/2016

Effective 10/01/2016, new claims processing functionality will make it quicker and easier for you to resolve
Therapeutic Dose Limit (THERDOSE) soft reject edits when dispensing medication for UnitedHealthcare
Community Plan in Louisiana members.

THERDOSE screening monitors single ingredient and combination acetaminophen products across multiple claims to determine cumulative daily use. If claims indicate that acetaminophen usage exceeds the U.S.  Food and Drug Administration (FDA)-approved maximum daily dose of 4 gm/day, the THERDOSE edit produces a soft reject: Drug Utilization Review (DUR) Reject 88.


Read More...

6

Sep

2016

Prime Therapeutics: Processing Update for Flu Mist for Covered Persons of Blue Cross and Blue Shield of Minnesota

Effective - September 19, 2016

Effective September 19, 2016, Blue Cross Blue Shield of Minnesota (BCBSMN) will no longer cover FluMist Quadrivalent as the live attenuated influenza vaccine (LAIV). According to the Center for Disease Control FluMist Quadrivalent should not be used during the 2016-2017 flu season.
Read More...

2

Sep

2016

Medimpact: Processing Information for Vensurance

Effective: September 1, 2016

MedImpact Healthcare Systems, Inc. began processing for Vensurance as of 9/1/2016.

Since you have already agreed to participate with MedImpact, there will be no information for you to return. Enclosed please find the following information to assist you in processing claims:

Read More...
First671673Last